SOPHiA GENETICS SA (SOPH) Q4 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning. My name is Drew, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sophia Genetics fourth quarter and full year 2023 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing star, then zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then 1 on your telephone keypad. To withdraw your question, please press star then 2. Please note this event is being recorded. I would now like to turn the conference over to Kellen Sanger, Sophia Genetics' Head of Strategy and Investor Relations. You may begin. Thank you, and good morning, everyone. Welcome to the Sophia Genetics fourth quarter and full year 2023 earnings conference call. Joining me today to discuss our results are Dr. Yergi Camblong, our co-founder and chief executive officer, and Ross Muecken, our chief financial officer and chief operating officer. I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated, and you should not place undue reliance on forward-looking statements. Additional information regarding these risks, uncertainties, and factors that could cause results to differ appears in the press release Sophia Genetics issued today and in the documents and reports filed by Sophia Genetics from time to time with the Securities and Exchange Commission. During this call, we will present both IFRS and non-IFRS financial measures. A reconciliation of...